Intuitive Surgical, Inc. (NASDAQ:ISRG) – Equities researchers at Wedbush issued their FY2019 earnings per share (EPS) estimates for shares of Intuitive Surgical in a research note issued on Tuesday. Wedbush analyst Levy. T anticipates that the medical equipment provider will post earnings per share of $25.64 for the year. Wedbush currently has a “Outperform” rating and a $835.00 target price on the stock.
Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 18th. The medical equipment provider reported $5.09 earnings per share for the quarter, beating the consensus estimate of $3.97 by $1.12. The company earned $674.20 million during the quarter, compared to analysts’ expectations of $664.72 million. Intuitive Surgical had a return on equity of 14.24% and a net margin of 27.21%. Intuitive Surgical’s quarterly revenue was up 13.4% on a year-over-year basis. During the same period last year, the business earned $4.42 earnings per share. COPYRIGHT VIOLATION NOTICE: “Wedbush Comments on Intuitive Surgical, Inc.’s FY2019 Earnings (ISRG)” was first published by Markets Daily and is owned by of Markets Daily. If you are viewing this news story on another domain, it was illegally stolen and reposted in violation of international trademark and copyright legislation. The original version of this news story can be read at https://www.themarketsdaily.com/2017/04/21/wedbush-comments-on-intuitive-surgical-inc-s-fy2019-earnings-isrg.html.
Several other equities analysts also recently weighed in on ISRG. Evercore ISI downgraded Intuitive Surgical from a “buy” rating to a “hold” rating and set a $690.00 price target for the company. in a research report on Wednesday, January 4th. Zacks Investment Research downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, January 17th. Canaccord Genuity reissued a “buy” rating on shares of Intuitive Surgical in a research report on Wednesday, January 25th. Bank of America Corp set a $800.00 price target on Intuitive Surgical and gave the stock a “buy” rating in a research report on Tuesday, February 14th. Finally, Barclays PLC reissued a “buy” rating and set a $800.00 price target on shares of Intuitive Surgical in a research report on Sunday, March 26th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and eleven have given a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $771.97.
Intuitive Surgical (NASDAQ:ISRG) traded down 0.14% during mid-day trading on Friday, hitting $813.31. The stock had a trading volume of 325,942 shares. The stock has a 50-day moving average price of $756.42 and a 200 day moving average price of $694.18. Intuitive Surgical has a 12-month low of $610.71 and a 12-month high of $817.20. The firm has a market cap of $31.55 billion, a P/E ratio of 43.42 and a beta of 0.55.
In other Intuitive Surgical news, CFO Marshall Mohr sold 2,000 shares of the business’s stock in a transaction dated Thursday, February 2nd. The stock was sold at an average price of $700.00, for a total transaction of $1,400,000.00. Following the transaction, the chief financial officer now owns 3,289 shares in the company, valued at $2,302,300. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP David J. Rosa sold 5,000 shares of the business’s stock in a transaction dated Wednesday, March 15th. The stock was sold at an average price of $750.00, for a total value of $3,750,000.00. Following the transaction, the executive vice president now owns 8,222 shares in the company, valued at approximately $6,166,500. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 34,118 shares of company stock worth $25,064,571. 3.10% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently modified their holdings of the company. Acropolis Investment Management LLC bought a new stake in Intuitive Surgical during the first quarter worth about $115,000. Bessemer Group Inc. increased its stake in Intuitive Surgical by 96.0% in the fourth quarter. Bessemer Group Inc. now owns 196 shares of the medical equipment provider’s stock worth $124,000 after buying an additional 96 shares during the period. Huntington National Bank increased its stake in Intuitive Surgical by 14.1% in the first quarter. Huntington National Bank now owns 170 shares of the medical equipment provider’s stock worth $130,000 after buying an additional 21 shares during the period. Stephens Inc. AR increased its stake in Intuitive Surgical by 77.1% in the third quarter. Stephens Inc. AR now owns 255 shares of the medical equipment provider’s stock worth $185,000 after buying an additional 111 shares during the period. Finally, Koch Industries Inc. bought a new stake in Intuitive Surgical during the fourth quarter worth about $205,000. Institutional investors own 91.16% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.